Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

294
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
294

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TOPSIS Multi-Attribute Decision-Making Model Utilizing Novel Distance Measure of Picture Fuzzy Sets and Its Application in Power Battery Recycling Evaluation.

Entropy (Basel, Switzerland)·2026
Same author

Colloidal transport controlled by surface anchoring in active nematic fluids.

Soft matter·2026
Same author

Noninvasive Predictive Model for Rapid Hemodynamic Optimization During Mechanical Circulatory Support.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Global daily CO<sub>2</sub> emissions from 1970 to 2024.

Scientific data·2026
Same author

Temporary circulatory support for cardiogenic shock: technology overview and limitations.

Expert review of medical devices·2026
Same author

A novel extended inverse Weibull distribution: Statistical analysis and application.

PloS one·2025
Same journal

Therapeutic plasma exchange added to CRRT combined with hemoperfusion in wasp sting-associated AKI: A multicenter retrospective cohort study.

The International journal of artificial organs·2026
Same journal

Development of an early prediction model for ICU-acquired weakness in sepsis using PNI and SII.

The International journal of artificial organs·2026
Same journal

Foot care behaviors and perceived exercise benefits and barriers in diabetic hemodialysis patients.

The International journal of artificial organs·2026
Same journal

First clinical experience with citrate-anticoagulated CVVHD-based low-flow ECCO<sub>2</sub>R in severe hypercapnic respiratory failure.

The International journal of artificial organs·2026
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K

Study on in vitro performance verification protocol for left ventricular assist device.

Shu Li1, Po-Lin Hsu2, Ye Hao1

  • 1Institute for Medical Device Control, National Institutes for Food and Drug Control, Beijing, China.

The International Journal of Artificial Organs
|November 5, 2019
PubMed
Summary
This summary is machine-generated.

A novel protocol using a mock circulatory loop verifies ventricular assist device performance and safety. This in vitro method ensures device reliability before clinical trials, advancing mechanical circulatory support.

Keywords:
Mock circulation loopfrank-startling lawhemodynamicsleft ventricular assist deviceverification protocol

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.2K

Related Experiment Videos

Last Updated: Jan 4, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.2K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Devices
  • Medical Device Verification

Background:

  • In vitro performance verification is crucial for ventricular assist devices (VADs).
  • Mock circulatory loops are essential for simulating physiological conditions.
  • Ensuring VAD safety and efficacy before in vivo testing is paramount.

Purpose of the Study:

  • To establish a comprehensive verification protocol for VADs.
  • To utilize a mock circulatory loop for in vitro performance assessment.
  • To define clear acceptance criteria for VAD functionality.

Main Methods:

  • Conducted a literature review to create a 12-test case verification matrix.
  • Defined test cases using physiological parameters and clinical hemodynamic indicators.
  • Customized a mock circulatory loop to simulate test conditions and verify a VAD.

Main Results:

  • Test cases based on clinical data defined operational extremes with safety margins.
  • The mock circulatory loop successfully generated test conditions and reproduced the Frank-Starling law.
  • VAD assistance effects on systemic flow, aortic pressure, and atrial pressure were verified.

Conclusions:

  • The developed protocol has been used to evaluate all VADs manufactured in China.
  • Several VADs evaluated with this protocol have advanced to clinical trials.
  • Ongoing clinical data observation aims to enhance the platform and promote VAD development.